Eurozone Spotify Stock Sheds All Gains After Q1 Earnings, But Analysts Are Impressed With the Performance – Spotify Technology (NYSE:SPOT) Read more
Biotechnology Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more
Biotechnology Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Small-Cap Cancer Drug Developer Agenus’ Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom – Agenus (NASDAQ:AGEN) Read more
Biotechnology Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck’s Pneumococcal Shots – Analyst Says – Vaxcyte (NASDAQ:PCVX) Read more
Biotechnology Johnson & Johnson’s Carvykti Stands Ahead Of Bristol Myers’ Rival Blood Cancer Therapy With FDA Approval For Wider Population – Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Analysts Express Confidence in Alnylam’s Hypertension Drug Despite Mixed Trial Data – Alnylam Pharmaceuticals (NASDAQ:ALNY) Read more
Biotechnology Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges – Alnylam Pharmaceuticals (NASDAQ:ALNY) Read more
Biotechnology Why Is JANX Therapeutics Stock Trading Higher Today? – Janux Therapeutics (NASDAQ:JANX) Read more
Biotechnology Amgen’s Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs – Amgen (NASDAQ:AMGN) Read more
